Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Status:
Not yet recruiting
Trial end date:
2028-02-01
Target enrollment:
Participant gender:
Summary
The LOLIPOP Trial is a large (n=4,300 patients) pragmatic, international, multicentre,
prospective, randomised, double blind, placebo-controlled, parallel assessment, stratified
safety and effectiveness superiority study.